CCM
Concord Medical Services Holdings Limited
There isn't enough reported data to score CCM yet.
OSCR
Oscar Health, Inc.
OSCR's fundamentals are strong: revenue grew 55% and its operating margin went from −1.9% to 5.4%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
CCM Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Weak |
CCM's profitability and balance sheet are currently under pressure. There isn't enough data to rate its revenue and cash flow.
OSCR Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Healthy | |
| Strong | |
| Strong |
OSCR's revenue, profitability, cash flow and balance sheet are all currently healthy.
CCM PE Valuation
CCM has no meaningful PE right now: it lost money over the past year.
OSCR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 12x | $31.94 | — |
| Current | 13x | $31.94 | — |
| Cheap | 21x | $52.73 | +65% |
| Fair | 35x | $87.23 | +173% |
| Expensive | 130x | $322 | +907% |
Historical ranges are pointers, not guarantees.
OSCR's PE is 13x, but its earnings don't support one, so it isn't a reliable read right now.
CCM Forward outlook
There aren't enough analyst estimates for CCM to show an outlook.
OSCR Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect strong earnings and revenue growth for OSCR, with profitability improving.
CCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q4 2025 | -$0.11 | +$0.24 |
| Q4 2024 | -$0.35 | +$3.06 |
| Q4 2023 | -$3.41 | +$2.20 |
| Q4 2020 | -$7.67 | -$1.31 |
| Q4 2019 | -$6.36 | -$2.22 |
| Q4 2018 | -$4.14 | -$0.85 |
| Q4 2017 | -$3.29 | -$0.29 |
| Q4 2016 | -$3.00 | -$2.13 |
CCM is still losing money, but far less than before: $0.11 per share over the past year, against $7.67 at its worst in late 2020.
OSCR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.61 | +5.6% |
| Q3 2026 | $2.47 | +$3.47 |
| Q2 2026 | $1.45 | +$2.14 |
| Q1 2026 | -$0.54 | -235% |
| Q4 2025 | -$1.69 | -1790% |
| Q3 2025 | -$1.00 | -$0.92 |
| Q2 2025 | -$0.69 | -$0.54 |
| Q1 2025 | $0.40 | +$0.82 |
| Q4 2024 | $0.10 | +$1.32 |
OSCR has the edge over CCM in the latest year-over-year earnings comparison.
CCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $69.1M | +20% |
| Q4 2024 | $57.6M | -29% |
| Q4 2023 | $80.6M | +14% |
| Q4 2022 | $70.8M | -2.8% |
| Q4 2021 | $72.9M | +118% |
| Q4 2020 | $33.5M | +12% |
| Q4 2019 | $29.8M | +3.9% |
| Q4 2018 | $28.6M | -42% |
CCM's revenue is growing: $69M last quarter, down 5.2% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -57% | +38 points |
| Q4 2024 | -139% | +3.1 points |
| Q4 2023 | -86% | +134 points |
| Q4 2022 | -111% | +46 points |
| Q4 2021 | -94% | -30 points |
| Q4 2020 | -142% | -105 points |
| Q4 2019 | -220% | -220 points |
| Q4 2018 | -157% | -187 points |
CCM's operating margin was −57% last quarter, up 38 points from the same quarter a year ago.
OSCR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +72% |
| Q2 2026 | $4.9B | +70% |
| Q1 2026 | $4.6B | +53% |
| Q4 2025 | $2.8B | +17% |
| Q3 2025 | $3B | +23% |
| Q2 2025 | $2.9B | +29% |
| Q1 2025 | $3B | +42% |
| Q4 2024 | $2.4B | +67% |
OSCR has the edge over CCM in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 3.5% | +7.8 points |
| Q2 2026 | 8% | +16 points |
| Q1 2026 | 15% | +5.4 points |
| Q4 2025 | -12% | -5.7 points |
| Q3 2025 | -4.3% | -2.3 points |
| Q2 2025 | -8.1% | -11 points |
| Q1 2025 | 9.8% | +1.1 points |
| Q4 2024 | -6.2% | +4 points |
OSCR's operating margin was 3.5% last quarter, up 7.8 points from the same quarter a year ago.
CCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$38.7M | +$43.6M |
| Q4 2024 | -$82.3M | -$23.9M |
| Q4 2023 | -$58.4M | +$7.5M |
| Q4 2022 | -$66M | +$29.8M |
| Q4 2021 | -$95.8M | -$36.1M |
| Q4 2020 | -$59.7M | +$4.5M |
| Q4 2019 | -$64.2M | -$33.6M |
| Q4 2018 | -$30.6M | -$21M |
CCM has burned cash in most quarters: −$245M over the past year, against −$250M the year before.
OSCR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.2B | -$238.2M |
| Q2 2026 | $2.1B | +316% |
| Q1 2026 | $2.6B | +200% |
| Q4 2025 | $662.8M | +95% |
| Q3 2025 | -$973.7M | -$466M |
| Q2 2025 | $499.8M | +2.1% |
| Q1 2025 | $869.5M | +38% |
| Q4 2024 | $340M | +17% |
OSCR usually generates cash, though not every quarter: the latest was −$1.2B, but it generated $4.1B over the past year.
CCM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | +900% | +118M shares |
| 3 years | +733% | +115M shares |
CCM has 131M diluted shares, up 900% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2018 | — |
| Q4 2017 | — |
| Q4 2016 | $4.6M |
| Q4 2015 | $3M |
| Q4 2013 | $902,679 |
| Q4 2012 | $6.5M |
| Q4 2011 | $1M |
| Q4 2009 | — |
OSCR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.9% | +13M shares |
| 1 year | +34% | +87.2M shares |
| 3 years | +55% | +123M shares |
| 5 years | +66% | +138M shares |
| Available history | +71% | +143M shares |
OSCR has the edge over CCM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
CCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2015 | 4.7x | High |
| Q4 2014 | 1.1x | Healthy |
| Q4 2013 | 2.2x | Moderate |
| Q4 2012 | 2.3x | Moderate |
CCM's net debt is about 4.7 years of its operating earnings (EBITDA).
OSCR Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -4.2x | Net Cash |
| Q2 2026 | -5.5x | Net Cash |
| Q1 2026 | -110.0x | Net Cash |
| Q1 2025 | -9.7x | Net Cash |
| Q4 2024 | -13.7x | Net Cash |
| Q3 2024 | -10.1x | Net Cash |
| Q2 2024 | -24.0x | Net Cash |
| Q1 2024 | -217.7x | Net Cash |
OSCR has more cash than debt.
CCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.7 | Neutral |
| Stochastic | 28.6 | Neutral |
CCM's weekly RSI is 44 (neutral) and its Stochastic is 29 (neutral).
OSCR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 58.7 | Neutral |
| Stochastic | 44.9 | Neutral |
OSCR's weekly RSI is 59 (neutral) and its Stochastic is 45 (neutral).
CCM PE vs Healthcare Sector
CCM has no meaningful PE right now: it lost money over the past year.
OSCR PE vs Healthcare Sector
| Metric | OSCR | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 50% below |
| PE % | 3 | 35 | 32 pts below |
OSCR is trading at 13x earnings, a 50% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
CCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.65 | 2.7% below |
| 20 week MA | $4.17 | 15% below |
| 50 week MA | $4.24 | 16% below |
| 100 week MA | $4.79 | 26% below |
| 200 week MA | $7.27 | 51% below |
CCM is in a downtrend: it's below all five of its weekly moving averages, and 51% below its 200-week average.
OSCR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $31.2 | 2.3% above |
| 20 week MA | $31.1 | 2.8% above |
| 50 week MA | $22.9 | 39% above |
| 100 week MA | $19.3 | 65% above |
| 200 week MA | $15.5 | 106% above |
OSCR has the edge over CCM on trend strength, trading above more of its moving averages.
CCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.3 | $29.1 | +6.6% |
| 2021 | $29.1 | $20.5 | -30% |
| 2022 | $20.5 | $16.6 | -19% |
| 2023 | $16.6 | $11.0 | -34% |
| 2024 | $11.0 | $5.02 | -54% |
| 2025 | $5.02 | $3.76 | -25% |
| 2026 YTD | $3.76 | $3.55 | -5.6% |
CCM has finished five years in a row lower, and it's down 5.6% so far in 2026.
OSCR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $31.0 | $8.02 | -74% |
| 2022 | $8.02 | $2.21 | -72% |
| 2023 | $2.21 | $9.15 | +314% |
| 2024 | $9.15 | $13.8 | +51% |
| 2025 | $13.8 | $14.9 | +8% |
| 2026 YTD | $14.9 | $31.9 | +114% |
OSCR has the edge over CCM on returns for 2026, with the stronger performance.